Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
Status
Enrolling
Conditions
Head and Neck Cancer
Study type
Observational
Funder types
Other
NIH
Identifiers
NCT00230308
ENT0008 (Other Identifier)
76537 (Other Identifier)
IRB-11402
R01DE027750 (U.S. NIH Grant/Contract)
11402 (Other Identifier)
Details and patient eligibility
About
Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.
Enrollment
500 estimated patients
Sex
All
Ages
18+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
All patients undergoing surgery at Stanford University for head and neck cancer.
Exclusion criteria
Non-Stanford patients.
Trial contacts and locations
1
Loading...
Central trial contact
Nikita Bedi
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems